Subscribe to our newsletter.
In today’s blog, we’re immersing ourselves in a pivotal area of molecular diagnostics that is revolutionizing our approach to sexually transmitted infections (STIs) – the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG).
CT and NG are two of the most common bacterial pathogens causing STIs worldwide. Infections by these bacteria, if left untreated, can lead to severe health complications, including pelvic inflammatory disease, infertility, and increased risk of HIV infection.
At Goffin Molecular Technologies, we’re not just observers in this transformative journey; we’re setting the pace. That’s why we’ve developed the Presto Diagnostic Kits for the detection of CT and NG. Our kits are the ‘gold standard’ in this field, marking a significant stride away from traditional detection methods towards a more specific and sensitive approach.
The accurate and early detection of CT and NG is vital for prompt and effective treatment, preventing complications and limiting the spread of these infections. The strength of our Presto kits lies in their highest specificity and sensitivity, offering unrivaled accuracy in detection.
100 and 500 Reaction Variants: Tailored for Every Research Setting
We understand that different laboratories have different needs. To cater to all research settings, Goffin offers the Presto Diagnostic Kits in two variants – 100 reactions and 500 reactions. This flexibility allows laboratories to select the version that best fits their needs, further reinforcing our commitment to adaptable and user-friendly solutions.
As a vanguard in the molecular diagnostics industry, our mission at Goffin extends beyond the creation of high-quality diagnostic tools. We’re passionate about paving the way for a world where STIs are detected and managed effectively.
With Goffin, you’re not just choosing top-tier molecular diagnostics tools; you’re joining a community of pioneers reshaping the future of STI detection.
We invite you to join us as we continue to lead in this groundbreaking field. Together, we can illuminate the unseen and usher in a new era of personalized, patient-centered healthcare in the fight against STIs.
New FlashDx GBS Test: A Key Tool for Protecting Maternal and Infant Health
Grand Opening of Healthy Lab in Beesd: Advancing Fitness and Nutrition Genetic Analysis
Introducing FlashDx Respiratory Panel 1.1: addition of Human Metapneumovirus and Bordetella pertussis